Congenital Coronary Artery Malformation Clinical Trials

Find Congenital Coronary Artery Malformation Clinical Trials Near You

AI-based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This multicenter retrospective study aims to develop, validate, and clinically apply an artificial intelligence (AI)-powered electrocardiography (ECG) algorithm for the diagnosis and prognostic prediction of cardiovascular diseases, including coronary artery disease and heart failure. By utilizing encrypted raw 12-lead ECG text data and deep neural network models, the study evaluates the effectiveness of AI-enhanced ECG in detecting cardiac abnormalities and predicting clinical outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

• Patients aged 19 years or older diagnosed with tachycardias (including PSVT, WPW syndrome, PVC, or VT) who have undergone an electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA).

• Patients with 12-lead electrocardiogram (ECG) records extractable as text (XML) files.

Locations
Other Locations
Republic of Korea
Inha University Hospital
RECRUITING
Incheon
Contact Information
Primary
Yongsoo Baek, MD, PhD
existsoo@inha.ac.kr
+82-32-890-2200
Time Frame
Start Date: 2023-12-01
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 10000
Treatments
Cardiovascular Disease and Tachycardia Cohort
Patients aged 19 years or older diagnosed with tachycardias (including PSVT, WPW syndrome, PVC, or VT) who underwent an electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA), with extractable 12-lead ECG text data\[cite: 1\].
Sponsors
Leads: Inha University Hospital

This content was sourced from clinicaltrials.gov